Busy. Please wait.
Log in with Clever
or

show password
Forgot Password?

Don't have an account?  Sign up 
Sign up using Clever
or

Username is available taken
show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
Your email address is only used to allow you to reset your password. See our Privacy Policy and Terms of Service.


Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.

Drugs for DM

Quiz yourself by thinking what should be in each of the black spaces below before clicking on it to display the answer.
        Help!  

Question
Answer
Stimuli for Insulin Secretion   Glucose, Amino Acids (esp. leucine, arginine), Sulfonyl urea drugs, Vagal stimulation (acetylcholine on M3 receptors)  
🗑
Mechanism for Insulin Release   ^ Glucose -> ^ATP in beta cells -> closure of ATP-dependent K channels -> depolarisation of cell membrane -> Ca channels open -> influx of Ca -> trigger insulin release.  
🗑
Actions of insulin   ^ glycogenesis in liver and muscles, decreases glycogenolysis and lipolysis. ^lipogenesis in adipose tissue, ^ activity of GLUT-4 transporters.  
🗑
Types of insulin replacement (7)   Insulin lispro, Insulin aspart, Insulin glulisine, Regular insulin, Neutral protamine Hagedorn (Isophane), Insulin detemir, Insulin glargine.  
🗑
Insulin lispro   Rapidly acting drug with a short duration (3-6h) which can be administered IV & mixed with other insulin drugs (eg. NPH). Available as Humalog Pen and administered subcutaneously 15min before a meal.  
🗑
Insulin aspart   Rapidly acting drug with short duration (4-5h), can be administered IV & mixed with other insulin drugs (NPH). Available as NovoRapid Flexpen & administered 15min before a meal.  
🗑
Insulin glulisine   Rapidly acting drug with a short duration (1.5h) which can be administered IV & mixed with other insulin drugs (eg. NPH). Administered subcutaneously 15min before a meal or 20 min after, as it appears in blood earlier with higher conc than reg insulin.  
🗑
Regular insulin   Short duration(5-8h) & slower acting (. Can be administered IV and mixed with other insulin (NPH) at varying concentrations for different patients (Mixtard).  
🗑
Neutral Protamine Hagedorn (NPH)/Isophane   Intermediate duration (~15h) and usually mixed with short duration insulin. Has an added component protamine to form dipole prep w/ insulin, releasing it slowly. Have varying pre-mixed preperations.  
🗑
Insulin detemir   Intermediate duration (12-24h), available as Levamir Flexpen. Contains a fatty acid side chain which enhances affinity to plasma albumin. This provides a delayed, reproducible absorption.  
🗑
Insulin glargine   Long duration (>20h), given once daily.  
🗑
Adverse effects of insulin   Hypoglycemia, lipodystrophy (lipoatrophy or lipohypertrophy). Factitious hypoglycemia in non-diabetics who inject a high dose of insulin. Redness at injection site  
🗑
Sulfonylureas: mode of action   Increases secretion of insulin by causing depolarisation of K+ channels in pancreatic B cells, promoting insulin release.  
🗑
Sulfonylureas: examples   1st gen: tolbutamide, 2nd gen: glibenclamide, glipizide. 3rd gen: glimepiride  
🗑
Sulfonylureas: toxicity   GIT related (nausea, cramps, diarrhea), dizziness, hypoglycemia, occasional rash (due to sulphur), teratogenicity in animals. Drug interation with salicylates.  
🗑
Meglitinide: mode of action   Same as sulfonylureas, just different receptors bound  
🗑
Meglitinide: toxicity   Headache, hypoglycemia.  
🗑
Meglitinide: example   Repaglinide, not commonly used.  
🗑
Biguanide: mode of action   Insulin sensitiser, increases insulin receptor density and sensitivity at tissue level, effect dependent on circulating insulin. Also: stimulates glycolysis, hepatic gluconeogenesis, decreased glucose absorp from GIT, reduced plasma glucagon.  
🗑
Biguanide: clinical uses   main drug for type 2 DM, also reduces hyperlipidemia. mixed with rosiglitazone (thiazolidinedione, another insulin sensitiser. (Avandamet).  
🗑
Biguanide: toxicity   GIT related (nausea,anorexia,diarrhea,vomiting), metallic taste, folate and vB12 def -> pernicious anemia (treated w supplements), lactic acidosis due to inhibition of hepatic gluconeog (seen by hypervent, myalgia, malaise).  
🗑
Biguanide: contraindications   liver disease, due to the reduced ability to undergo gluconeogenesis and breakdown lactic acid (a substrate), excessive alcoholism and shock.  
🗑


   

Review the information in the table. When you are ready to quiz yourself you can hide individual columns or the entire table. Then you can click on the empty cells to reveal the answer. Try to recall what will be displayed before clicking the empty cell.
 
To hide a column, click on the column name.
 
To hide the entire table, click on the "Hide All" button.
 
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
 
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.

 
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how
Created by: Aurorahx
Popular Pharmacology sets